Is PGEN a good stock to buy? We came across a bullish thesis on Precigen, Inc. on Valueinvestorsclub.com by coalone. In this article, we will summarize the bulls’ thesis on PGEN. Precigen, Inc.’s share was trading at $4.0200 as of April 28th. PGEN’s forward P/E was 9.14 according to Yahoo Finance.
Pressmaster/Shutterstock.com
Precigen (PGEN) is a biotechnology company that has transitioned from a clinical-stage developer to a commercial rare disease platform following the August 2025...
